APO RESEARCH · REPORT
Albendazole
Albendazole is a high-efficiency and low-toxic broad-spectrum anthelmintic drug. It was successfully developed and marketed by Skipper in the 1980s. It can be used clinically to ward off roundworms, pinworms, tapeworms, whipworms, hookworms, and anastomosis. After being metabolized to sulfoxides or sulfones in the body, it inhibits the parasite's absorption of glucose, leading to depletion of the body's glycogen, or inhibits the fumarate reductase system, hinders the production of ATP, and makes the parasite unable to survive and reproduce. Albendazole is a benzimidazole derivative, which is rapidly metabolized into sulfoxide, sulfone alcohol and 2-aminosulfone alcohol in the body, selectively and irreversibly inhibits the cytoplasmic microtubule system of intestinal wall cells of parasites Polymerization, blocking its uptake of various nutrients and glucose, leading to depletion of endogenous glycogen, and inhibiting the fumarate reductase system, preventing the production of adenosine triphosphate, making the worm unable to survive and reproduce. Similar to mebendazole, albendazole can also cause the degeneration of cytoplasmic microtubules in the intestinal cells of worms and bind to its tubulin, causing intracellular transport blockage, resulting in the accumulation of secretory particles in the Golgi body, the cytoplasm is gradually dissolved, and the cells are completely absorbed Denaturation causes death of the worm. Albendazole completely kills hookworm eggs and whipworm eggs and partially kills roundworm eggs. In addition to killing and repelling various nematodes parasitic in animals, it also has obvious killing and repelling effects on tapeworms and cysticercosis.
Product & engineering
Understand the product.
Albendazole is a high-efficiency and low-toxic broad-spectrum anthelmintic drug. It was successfully developed and marketed by Skipper in the 1980s. It can be used clinically to ward off roundworms, pinworms, tapeworms, whipworms, hookworms, and anastomosis. After being metabolized to sulfoxides or sulfones in the body, it inhibits the parasite's absorption of glucose, leading to depletion of the body's glycogen, or inhibits the fumarate reductase system, hinders the production of ATP, and makes the parasite unable to survive and reproduce. Albendazole is a benzimidazole derivative, which is rapidly metabolized into sulfoxide, sulfone alcohol and 2-aminosulfone alcohol in the body, selectively and irreversibly inhibits the cytoplasmic microtubule system of intestinal wall cells of parasites Polymerization, blocking its uptake of various nutrients and glucose, leading to depletion of endogenous glycogen, and inhibiting the fumarate reductase system, preventing the production of adenosine triphosphate, making the worm unable to survive and reproduce. Similar to mebendazole, albendazole can also cause the degeneration of cytoplasmic microtubules in the intestinal cells of worms and bind to its tubulin, causing intracellular transport blockage, resulting in the accumulation of secretory particles in the Golgi body, the cytoplasm is gradually dissolved, and the cells are completely absorbed Denaturation causes death of the worm. Albendazole completely kills hookworm eggs and whipworm eggs and partially kills roundworm eggs. In addition to killing and repelling various nematodes parasitic in animals, it also has obvious killing and repelling effects on tapeworms and cysticercosis.
Selected research
Industry Research
Albendazole Industry Research Report 2026
Market perspective
Albendazole is a high-efficiency and low-toxic broad-spectrum anthelmintic drug. It was successfully developed and marketed by Skipper in the 1980s. It can be used clinically to ward off roundworms, pinworms, tapeworms, whipworms, hookworms, and anastomosis. After being metabolized to sulfoxides or sulfones in the body, it inhibits the parasite's absorption of glucose, leading to depletion of the body's glycogen, or inhibits the fumarate reductase system, hinders the production of ATP, and makes the parasite unable to survive and reproduce. Albendazole is a benzimidazole derivative, which is rapidly metabolized into sulfoxide, sulfone alcohol and 2-aminosulfone alcohol in the body, selectively and irreversibly inhibits the cytoplasmic microtubule system of intestinal wall cells of parasites Polymerization, blocking its uptake of various nutrients and glucose, leading to depletion of endogenous glycogen, and inhibiting the fumarate reductase system, preventing the production of adenosine triphosphate, making the worm unable to survive and reproduce. Similar to mebendazole, albendazole can also cause the degeneration of cytoplasmic microtubules in the intestinal cells of worms and bind to its tubulin, causing intracellular transport blockage, resulting in the accumulation of secretory particles in the Golgi body, the cytoplasm is gradually dissolved, and the cells are completely absorbed Denaturation causes death of the worm. Albendazole completely kills hookworm eggs and whipworm eggs and partially kills roundworm eggs. In addition to killing and repelling various nematodes parasitic in animals, it also has obvious killing and repelling effects on tapeworms and cysticercosis.
This is a relatively concentrated market, mainly due to the particularity of the pharmaceutical industry, where there are higher operating licenses and barriers, technical barriers, capital barriers and environmental barriers, so the concentration is higher. From the perspective of the global market, the original research firm GSK's albendazole accounts for more than 40% of the entire industry and is the leading enterprise in the albendazole industry. From the perspective of the Chinese market, the market concentration is also relatively high. The main companies are Huazhong Pharmaceutical and Jiangsu Qihui, which together account for 70% of the domestic market.
Report Scope
Read the full market overview
This report quantifies the global Albendazole market in terms of revenue (US$ million) and, where applicable, sales volume (K MT), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K MT) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Albendazole Market by Company
GlaxoSmithKline
Huazhong Pharmaceutical
Jiangsu Qihui
Sequent Scientific
K.A. Malle Pharmaceuticals
Lasa Supergenerics Limited
Zhongjia Pharmaceutical
Fredun Pharmaceuticals Ltd
Supharma Chem
Salius Pharma
Albendazole Segment by Type
Tablet
Capsule
Other
Albendazole Segment by Application
Human
Veterinary
Albendazole Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Albendazole market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Albendazole and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Albendazole.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Albendazole manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Albendazole by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Albendazole in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Tablet
- Capsule
- Other
Applications
- Human
- Veterinary
Companies covered
- GlaxoSmithKline
- Huazhong Pharmaceutical
- Jiangsu Qihui
- Sequent Scientific
- K.A. Malle Pharmaceuticals
- Lasa Supergenerics Limited
- Zhongjia Pharmaceutical
- Fredun Pharmaceuticals Ltd
- Supharma Chem
- Salius Pharma
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Albendazole Market Size (2021-2032)
- 2.2.2 Global Albendazole Sales (2021-2032)
- 2.2.3 Global Albendazole Market Average Price (2021-2032)
- 2.3 Albendazole by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Tablet
- 2.3.3 Capsule
- 2.3.4 Other
- 2.4 Albendazole by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Human
- 2.4.3 Veterinary
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Albendazole Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Albendazole Sales (K MT) of Manufacturers (2021-2026)
- 3.3 Global Albendazole Revenue of Manufacturers (2021-2026)
- 3.4 Global Albendazole Average Price by Manufacturers (2021-2026)
- 3.5 Global Albendazole Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Albendazole, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Albendazole, Product Type & Application
- 3.8 Global Manufacturers of Albendazole, Established Date
- 3.9 Global Albendazole Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 GlaxoSmithKline
- 4.1.1 GlaxoSmithKline Company Information
- 4.1.2 GlaxoSmithKline Business Overview
- 4.1.3 GlaxoSmithKline Albendazole Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 GlaxoSmithKline Albendazole Product Portfolio
- 4.1.5 GlaxoSmithKline Recent Developments
- 4.2 Huazhong Pharmaceutical
- 4.2.1 Huazhong Pharmaceutical Company Information
- 4.2.2 Huazhong Pharmaceutical Business Overview
- 4.2.3 Huazhong Pharmaceutical Albendazole Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Huazhong Pharmaceutical Albendazole Product Portfolio
- 4.2.5 Huazhong Pharmaceutical Recent Developments
- 4.3 Jiangsu Qihui
- 4.3.1 Jiangsu Qihui Company Information
- 4.3.2 Jiangsu Qihui Business Overview
- 4.3.3 Jiangsu Qihui Albendazole Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Jiangsu Qihui Albendazole Product Portfolio
- 4.3.5 Jiangsu Qihui Recent Developments
- 4.4 Sequent Scientific
- 4.4.1 Sequent Scientific Company Information
- 4.4.2 Sequent Scientific Business Overview
- 4.4.3 Sequent Scientific Albendazole Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Sequent Scientific Albendazole Product Portfolio
- 4.4.5 Sequent Scientific Recent Developments
- 4.5 K.A. Malle Pharmaceuticals
- 4.5.1 K.A. Malle Pharmaceuticals Company Information
- 4.5.2 K.A. Malle Pharmaceuticals Business Overview
- 4.5.3 K.A. Malle Pharmaceuticals Albendazole Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 K.A. Malle Pharmaceuticals Albendazole Product Portfolio
- 4.5.5 K.A. Malle Pharmaceuticals Recent Developments
- 4.6 Lasa Supergenerics Limited
- 4.6.1 Lasa Supergenerics Limited Company Information
- 4.6.2 Lasa Supergenerics Limited Business Overview
- 4.6.3 Lasa Supergenerics Limited Albendazole Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Lasa Supergenerics Limited Albendazole Product Portfolio
- 4.6.5 Lasa Supergenerics Limited Recent Developments
- 4.7 Zhongjia Pharmaceutical
- 4.7.1 Zhongjia Pharmaceutical Company Information
- 4.7.2 Zhongjia Pharmaceutical Business Overview
- 4.7.3 Zhongjia Pharmaceutical Albendazole Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Zhongjia Pharmaceutical Albendazole Product Portfolio
- 4.7.5 Zhongjia Pharmaceutical Recent Developments
- 4.8 Fredun Pharmaceuticals Ltd
- 4.8.1 Fredun Pharmaceuticals Ltd Company Information
- 4.8.2 Fredun Pharmaceuticals Ltd Business Overview
- 4.8.3 Fredun Pharmaceuticals Ltd Albendazole Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Fredun Pharmaceuticals Ltd Albendazole Product Portfolio
- 4.8.5 Fredun Pharmaceuticals Ltd Recent Developments
- 4.9 Supharma Chem
- 4.9.1 Supharma Chem Company Information
- 4.9.2 Supharma Chem Business Overview
- 4.9.3 Supharma Chem Albendazole Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Supharma Chem Albendazole Product Portfolio
- 4.9.5 Supharma Chem Recent Developments
- 4.10 Salius Pharma
- 4.10.1 Salius Pharma Company Information
- 4.10.2 Salius Pharma Business Overview
- 4.10.3 Salius Pharma Albendazole Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Salius Pharma Albendazole Product Portfolio
- 4.10.5 Salius Pharma Recent Developments
5 Global Albendazole Market Scenario by Region
- 5.1 Global Albendazole Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Albendazole Sales by Region: 2021-2032
- 5.2.1 Global Albendazole Sales by Region: 2021-2026
- 5.2.2 Global Albendazole Sales by Region: 2027-2032
- 5.3 Global Albendazole Revenue by Region: 2021-2032
- 5.3.1 Global Albendazole Revenue by Region: 2021-2026
- 5.3.2 Global Albendazole Revenue by Region: 2027-2032
- 5.4 North America Albendazole Market Facts & Figures by Country
- 5.4.1 North America Albendazole Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Albendazole Sales by Country (2021-2032)
- 5.4.3 North America Albendazole Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Albendazole Market Facts & Figures by Country
- 5.5.1 Europe Albendazole Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Albendazole Sales by Country (2021-2032)
- 5.5.3 Europe Albendazole Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Albendazole Market Facts & Figures by Country
- 5.6.1 Asia Pacific Albendazole Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Albendazole Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Albendazole Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Albendazole Market Facts & Figures by Country
- 5.7.1 South America Albendazole Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Albendazole Sales by Country (2021-2032)
- 5.7.3 South America Albendazole Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Albendazole Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Albendazole Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Albendazole Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Albendazole Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Albendazole Sales by Type (2021-2032)
- 6.1.1 Global Albendazole Sales by Type (2021-2032) & (K MT)
- 6.1.2 Global Albendazole Sales Market Share by Type (2021-2032)
- 6.2 Global Albendazole Revenue by Type (2021-2032)
- 6.2.1 Global Albendazole Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Albendazole Revenue Market Share by Type (2021-2032)
- 6.3 Global Albendazole Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Albendazole Sales by Application (2021-2032)
- 7.1.1 Global Albendazole Sales by Application (2021-2032) & (K MT)
- 7.1.2 Global Albendazole Sales Market Share by Application (2021-2032)
- 7.2 Global Albendazole Revenue by Application (2021-2032)
- 7.2.1 Global Albendazole Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Albendazole Revenue Market Share by Application (2021-2032)
- 7.3 Global Albendazole Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Albendazole Value Chain Analysis
- 8.1.1 Albendazole Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Albendazole Production Mode & Process
- 8.2 Albendazole Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Albendazole Distributors
- 8.2.3 Albendazole Customers
9 Global Albendazole Analyzing Market Dynamics
- 9.1 Albendazole Industry Trends
- 9.2 Albendazole Industry Drivers
- 9.3 Albendazole Industry Opportunities and Challenges
- 9.4 Albendazole Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst